http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101659661-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02f24694b4445e31254823f04656311e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
filingDate | 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e28406de8bd8365527f8c10dc418c17f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6374138b1a1cf66e6a1fb43894c431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b27d8c8597a59620754e99c794596f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07470383aeafca0c2da876af7c8a20b4 |
publicationDate | 2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-101659661-A |
titleOfInvention | 2-aryl-3-(tetrahydro-2H-pyran-4-yl)-N-aryl-heterocyclic-propionamide compound, medicinal composition thereof and application thereof |
abstract | The invention discloses a 2-aryl-3-(tetrahydro-2H-pyran-4-yl)-N-aryl-heterocyclic-propionamide compound with a structure of a formula I, a medicinal composition containing the compound, and application of the compound in preparing medicaments for treating and/or preventing diseases of metabolic system disorder. The compound provided by the invention has better actuation activity to human insulin and rat liver glucokinase, and improves the activity and the pharmacological property of a small molecular activator of the glucokinase. |
priorityDate | 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 323.